MAI Capital Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.77M Buy
86,534
+607
+0.7% +$47.5K 0.05% 289
2025
Q1
$6.23M Buy
85,927
+21,192
+33% +$1.54M 0.05% 291
2024
Q4
$4.79M Buy
64,735
+1,127
+2% +$83.4K 0.04% 322
2024
Q3
$4.2M Buy
63,608
+152
+0.2% +$10K 0.04% 274
2024
Q2
$5.86M Buy
63,456
+1,463
+2% +$135K 0.06% 235
2024
Q1
$5.92M Buy
61,993
+1,610
+3% +$154K 0.06% 225
2023
Q4
$4.6M Buy
60,383
+49,772
+469% +$3.8M 0.06% 209
2023
Q3
$735K Buy
10,611
+351
+3% +$24.3K 0.01% 504
2023
Q2
$968K Sell
10,260
-503
-5% -$47.4K 0.01% 431
2023
Q1
$890K Buy
10,763
+1,586
+17% +$131K 0.01% 445
2022
Q4
$685K Sell
9,177
-164
-2% -$12.2K 0.01% 511
2022
Q3
$772K Sell
9,341
-1,272
-12% -$105K 0.01% 414
2022
Q2
$1.01M Buy
10,613
+963
+10% +$91.6K 0.02% 362
2022
Q1
$1.14M Buy
9,650
+654
+7% +$77K 0.02% 359
2021
Q4
$1.17M Buy
8,996
+5,268
+141% +$682K 0.02% 367
2021
Q3
$422K Buy
3,728
+756
+25% +$85.6K 0.01% 532
2021
Q2
$308K Buy
2,972
+86
+3% +$8.91K 0.01% 577
2021
Q1
$241K Buy
2,886
+156
+6% +$13K 0.01% 612
2020
Q4
$249K Sell
2,730
-121
-4% -$11K 0.01% 548
2020
Q3
$228K Sell
2,851
-758
-21% -$60.6K 0.01% 487
2020
Q2
$249K Buy
3,609
+105
+3% +$7.24K 0.01% 449
2020
Q1
$220K Buy
3,504
+438
+14% +$27.5K 0.01% 450
2019
Q4
$238K Buy
3,066
+3
+0.1% +$233 0.01% 493
2019
Q3
$225K Buy
+3,063
New +$225K 0.01% 454
2019
Q2
Sell
-3,201
Closed -$204K 531
2019
Q1
$204K Buy
+3,201
New +$204K 0.01% 418